155
Participants
Start Date
March 31, 2007
Primary Completion Date
October 25, 2012
Study Completion Date
October 25, 2012
GnRHant - Ganirelix acetate
1 subcutaneous injection at 0.5 mg then daily injections of 0.25 mg for 6 days (total of 7 days of injections); testing will occur on injection day 4 and day 7
Transdermal estradiol patch
0.075mg/d starting on day 4 of the injections following testing time point two; continue for 3 days and retest (day 7)
Transdermal placebo patch
Starting on day 4 of the injections following testing time point two; continue for 3 days and retest (day 7)
University of Colorado Anschutz Medical Center, Clinical Translational Research Center and Exercise Research Laboratory, Aurora
National Institute on Aging (NIA)
NIH
University of Colorado, Denver
OTHER